Delivery Kinetics for Topical Drugs
PharmaTech
SEPTEMBER 3, 2022
API permeation into the skin modulates the efficacy of topical treatments.
This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
PharmaTech
SEPTEMBER 3, 2022
API permeation into the skin modulates the efficacy of topical treatments.
PharmaVoice
SEPTEMBER 1, 2023
Psycheceutical is developing a back-of-the-neck topical treatment for ketamine but believes the delivery route holds promise for far more drugs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaTech
NOVEMBER 22, 2023
In this episode of Drug Digest, Pharmaceutical Technology’s European/Senior Editor, Felicity Thomas, chats about the biggest trends impacting oral and topical drug delivery and how these trends are impacting the excipient sector with Nick DiFranco and Ashley Rezak from Lubrizol Life Science Health.
European Pharmaceutical Review
AUGUST 22, 2023
According to UK Research and Innovation ( UKRI ), £13 million is set to fund medicine manufacturing in the UK, through a focus on innovation in intracellular drug delivery, digitalisation and automation and nucleic acid medicines. The investment aims to improve vaccines and shorten the time it takes to produce medicines.
Pharmaceutical Technology
JUNE 1, 2023
A new intracellular drug delivery centre will be established in the UK to support potential ribonucleic acid (RNA) vaccines and therapeutics , as well as the development of innovative drug delivery technologies. Another key focus area will be the creation of a framework to develop advanced nano-delivery systems.
European Pharmaceutical Review
MARCH 10, 2023
A review by researchers on ocular drug delivery discussed strategies that could enhance ocular bioavailability. Currently, effective topical administration is challenging as the industry aims to prolong drug residence time and guarantee appropriate ocular permeation.
European Pharmaceutical Review
OCTOBER 13, 2022
The research, published in the journal Science Robotics described how the new drug delivery system can transport large protein and small-molecule drugs, like vancomycin, an antibiotic peptide. Traditionally, delivering protein drugs orally has been challenging.
European Pharmaceutical Review
DECEMBER 22, 2022
The success of mRNA vaccines against SARS-CoV-2 has quickly catapulted mRNA therapeutics as a disruptive, expanding drug category” The term ‘mRNA’ has become commonplace globally. The success of mRNA vaccines against SARS-CoV-2 has quickly catapulted mRNA therapeutics as a disruptive, expanding drug category.
Pharmaceutical Technology
FEBRUARY 16, 2023
The collaboration will combine the Optejet dispensing technology of Eyenovia with the APNT nanoparticle formulation platform of Formosa to develop topical therapeutics. The Optejet microdose formulation and delivery platform use Microdose Array Print (MAP) technology for delivering 6ml-8ml of the drug.
pharmaphorum
OCTOBER 12, 2022
Sustainability for Injectable Delivery Devices. Sustainability for Injectable Delivery Devices. Connected Drug Delivery Devices. Hear about new technological advances in the delivery of large volume drugs. Marc Moal, Corporate Programme Vice President, Devices and Delivery Solutions, Novo Nordisk.
Pharmaceutical Technology
MAY 5, 2023
The US Food and Drug Administration (FDA) has accepted Optinose’s supplemental new drug application (sNDA) for Xhance (fluticasone propionate) to treat chronic rhinosinusitis, which is now under review. The regulator has set 16 December 2023 as a prescription drug user fee act (PDUFA) target goal date.
Pharmaceutical Technology
AUGUST 2, 2022
GreenLight’s process from formulation of the drug substance and lipid nanoparticle to bulk drug product can be carried out in this facility. The RNA platform of Samsung Biologics permitted GreenLight to move from mRNA vaccine conceptualisation to the delivery of released clinical trial material in under two years.
European Pharmaceutical Review
JANUARY 29, 2024
1 Some five years after the initial NDMA (N-nitrosodimethylamine) contamination issue 2 initially affecting valsartan drug substance, then other active pharmaceutical ingredients (APIs), eg, sartans, ranitidine, metformin, etc; the toxic short alkyl chain N-nitrosamine issue appears, if not resolved, then well on the way to resolution.
Pharmaceutical Technology
APRIL 4, 2023
Gennova Biopharmaceuticals has applied for an emergency use authorisation (EUA) from the Drug Controller General of India (DCGI) for its mRNA-based Omicron-specific Covid-19 booster vaccine. Dubbed GEMCOVAC-OM, the needle-free vaccine will be delivered intradermally with the PharmaJet Tropis Precision Delivery System (PDS).
European Pharmaceutical Review
NOVEMBER 11, 2022
A paper, published in the European Journal of Pharmaceutical Sciences identified the quality assurance (QA) challenges and trends of analytical techniques in ocular drug delivery and formulation, focusing on treatments for glaucoma. seven covered testing in combination drugs. for latanoprost.”
Pharmaceutical Technology
OCTOBER 19, 2022
It has combined expertise in otology, gene therapy and inner ear drug delivery to meet the requirements of individuals with disabling hearing loss globally. Topic sponsors are not involved in the creation of editorial content. AK-OTOF is the lead product candidate of the company.
Clarivate
SEPTEMBER 19, 2023
Finally, we look at recent Nobel Prizes and judge whether the topics identified would likely receive attention within next few years. Although we do not forecast a topic or researchers for the Nobel Prize in the year we name them Citation Laureates, we do try to anticipate near-term awards.
Pharmaceutical Technology
MAY 24, 2023
The AMP programme is a public-private partnership between a number of biopharmaceutical and life sciences companies, the US Food and Drug Administration (FDA) and the National Institutes of Health (NIH), along with non-profit and other organisations. Topic sponsors are not involved in the creation of editorial content.
European Pharmaceutical Review
OCTOBER 5, 2023
What are the key topics you plan to cover during your session at CPHI Barcelona? I firmly believe that manufacturing plays a pivotal role in this endeavour, and I will delve into topics such as production system optimisation and the standardisation of chemistry, manufacturing, and control (CMC) processes.”
Pharmaceutical Technology
APRIL 21, 2023
Samyang Holdings Biopharm Division CEO Young-Joon Lee stated: “LG Chem has exceptional research and development expertise in innovative drug development and a number of promising new drug pipelines. This is expected to shorten the development time of new drugs and to support personalised treatments.
pharmaphorum
NOVEMBER 1, 2022
Further topics to be examined comprise of novel RNA modalities encompassing self-amplifying RNA, saRNA, circular RNA, lnc RNA and many more. Benefits of attending: Explore how mRNA leads the way in the genetic medicine space as the next generation of novel drug modalities.
Pharmaceutical Technology
MAY 15, 2023
The US Food and Drug Administration (FDA) has given orphan drug designation to SiSaf’s siRNA [a double-stranded RNA molecule that is non-coding] therapeutic, SIS-101-ADO, for the treatment of autosomal dominant osteopetrosis type 2 (ADO2), a rare and serious skeletal disorder in children.
Pharmaceutical Technology
SEPTEMBER 29, 2022
Scribe’s CasX-Editors (XE), a suite of custom engineering genome editing and delivery tools based on new foundations such as the CasX enzyme, will back Sanofi’s developing NK cell therapies pipeline for cancer. Topic sponsors are not involved in the creation of editorial content.
pharmaphorum
OCTOBER 28, 2022
Nina’s role is to ensure that patients have faster access to the most promising new treatments, taxpayers get better value for money in drug expenditure and the route to funding is speeded up for responsibly priced, promising drugs. Sean Richardson , VP & General Manager UK & Ireland, Alexion. Sean Richardson.
Pharmaceutical Technology
NOVEMBER 21, 2022
Additionally, the wide-ranging expertise of RVAC in mRNA, vaccine and drug delivery technologies, and its capabilities in research and development (R&D), biopharmaceutical manufacturing, clinical development and marketing is leveraged under the partnership. Topic sponsors are not involved in the creation of editorial content.
Pharmaceutical Technology
APRIL 4, 2023
The company will undertake a technology transfer and feasibility study for a drug product focused on the treatment of IPF at its centre of cell and gene expertise in Milan, Italy. Topic sponsors are not involved in the creation of editorial content. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.
Clarivate
JUNE 29, 2023
As when any new technology appears on the horizon, a tremendous amount of overheated hyperbole has dominated coverage of the topic in the months since. Clarivate was an early adopter of AI technology that enables researchers to optimize treatment development from early-stage drug discovery through commercialization.
Pharmaceutical Technology
AUGUST 24, 2022
According to the deal, Lacerta will oversee the discovery of the capsids, as well as their screening and validation, while Prevail will carry out the preclinical and Investigational New Drug-facilitating studies with therapeutic payloads. . Topic sponsors are not involved in the creation of editorial content.
Pharmaceutical Technology
OCTOBER 18, 2022
Moderna has entered an agreement with Gavi, the Vaccine Alliance, with regard to the delivery of Covid-19 vaccines to lower-income countries supported by the Gavi COVAX Advance Market Commitment (AMC). In August, the company sought emergency use authorization (EUA) from the US Food and Drug Administration for mRNA-1273.222, its BA.4/BA.5
Pharmaceutical Technology
JUNE 8, 2023
Both the aerosol delivery and the therapy itself were well tolerated, with no related adverse events. The next month, the US Food and Drug Administration (FDA) placed the program on hold. Topic sponsors are not involved in the creation of editorial content. The company plans to provide an update on this program in H2 2023.
Pharmaceutical Technology
MARCH 3, 2023
“The Halle customer service team is a “one-stop-shop” for client requests when it comes to commercial drug product manufacturing,” explains Dragitsch. The batch release process itself incorporates different sub-processes to be followed by different departments.
European Pharmaceutical Review
SEPTEMBER 25, 2023
Of particular interest is the potential of using NMR relaxometry as a point of receipt technique to satisfy regulatory identity testing requirements for active pharmaceutical ingredients (API) and drug product materials. Validation of capillary zone electrophoretic method for evaluating monoclonal antibodies and antibody-drug conjugates.
pharmaphorum
JUNE 30, 2022
At the 2022 Drug Information Association (DIA) annual meeting last week, it was inspiring to connect with fellow research and development (R&D) stakeholders, regulators, health and digital data partners and more to navigate challenges in drug development that impact patients globally. Delivery models. Patient journey.
Pharmaceutical Technology
JANUARY 12, 2023
The collaboration will use the vector biology, manufacturing capabilities and the drug development experience of Solid Biosciences and Phlox Therapeutics’ knowledge in genetic cardiomyopathies and RNA therapies. Topic sponsors are not involved in the creation of editorial content.
PM360
DECEMBER 14, 2023
The downside to this potent drug is it can be quite toxic and poses risks to the human body even in small doses. Some commonly unknown topics touched upon are how sound reaches the brain, what noise-induced hearing damage looks like, and how tinnitus really affects the ear. The videos can be viewed at www.gn.com/inside-the-ear.
PM360
OCTOBER 13, 2023
Fine-tuning models can target domains and generate prompts to tag the content into relevant topics. These content topics can then be utilized to create message sets containing information that is pertinent to a specific channel and topic.
PM360
DECEMBER 14, 2023
Personalized news scans ensure clinicians get the latest news, drug updates, and guideline analyses to support day-to-day practice, while roundtables, discussions, and podcasts offer perspectives on practice trends and innovations from leading community and academic thought-leaders.
Contrarian Sales Techniques
JANUARY 23, 2024
It delves into the science behind the drugs, equipping you with knowledge of anatomy, physiology, and therapeutic areas. Master the art of time management: Craft a realistic study schedule, allocating dedicated blocks for specific topics. Imagine a treasure map, guiding you through the pharmaceutical jungle. Salary expectations?
Pharmaceutical Technology
APRIL 5, 2023
More than a decade after the first patient was treated with a CAR-T therapy, six therapies relying on the same principles have been approved by the US Food and Drug Administration (FDA) and marketed to thousands of patients. We also have the challenge of delivery. Topic sponsors are not involved in the creation of editorial content.
Clarivate
DECEMBER 14, 2021
2021 surveys of patients and physicians in the United States conducted by Clarivate show that: Much of care delivery has gone virtual. 2021 study had researched prescription drug topics online in the past year. Physicians indicate that nearly 1 in 4 patient consults (23%) are now performed virtually. hours seeing patients.
Clarivate
NOVEMBER 17, 2021
Mike Ward: Celine, what’s your take on this topic? They’re here to ensure that their company meets the regulatory requirements in the different activities of the organization, whether they are from the submission, to the manufacturing or even the advertising of the given drugs or other pharmaceutical products.
pharmaphorum
JANUARY 27, 2023
Late last year, pharmaphorum caught up with Dr Karen Mullen, chief medical officer and VP of clinical & medical affairs at global drug development consultancy Boyds. We talk a lot in clinical trials and drug development about benefit,” Dr Mullen said. But who is benefitting?
Clarify Health
NOVEMBER 1, 2019
It is also important to look at the underlying metrics driving these costs, such as post-acute care usage and expensive drug prescribing patterns. When online shopping, you need to understand shipping and delivery time and rates. To learn more about this topic, download our Network Design Playbook.
Silver Line CRM
MAY 27, 2020
Even that is less relevant now given the nature of today’s specialty drugs (e.g. HCPs are consumers in their personal lives — so they have high expectations around technology and delivery mechanisms that provide a personalized and timely customer experience along with their solution. biologics) that can’t just be dropped off. .
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content